RxReady

PEBC Diabetes and Endocrine Practice Questions

Insulin, GLP-1 agonists, osteoporosis and thyroid disease: ten endocrine questions in the style of the PEBC MCQ.

Updated November 13, 2026. Written by RxReady to the 2026 PEBC blueprint. These are practice questions, not real or recalled exam questions.

Diabetes is one of the most heavily tested therapeutic areas on the PEBC MCQ, and it reaches beyond drug choice into counselling, storage, sick-day rules and insulin calculations. Endocrine questions also cover bone health, thyroid disease and corticosteroids.

These ten questions include insulin dosing and storage, GLP-1 receptor agonists, diabetes prevention, alcohol and insulin, alendronate counselling, hyperthyroidism in pregnancy and adrenal suppression with steroids, written to Diabetes Canada and Osteoporosis Canada guidance.

Pay attention to what the patient can safely do at home. Many of these answers are about practical counselling rather than the drug itself.

Practice by topic

Ten diabetes and endocrine questions

Question 1 · Osteoporosis

GH, a 68-year-old woman, is starting alendronate 70 mg once weekly. Which of the following counselling points is correct?

  1. ATake with breakfast and orange juice to reduce stomach upset
  2. BLie down for 30 minutes after the dose to prevent dizziness
  3. CTake at bedtime together with the calcium supplement
  4. DTake with plain water 30 min before breakfast; stay upright
Show the answer

Answer: D) Take with plain water 30 min before breakfast; stay upright

Oral bisphosphonates have very low bioavailability (under 1%) that is further reduced by food, juice, coffee, calcium and other medications, so alendronate is taken with a full glass of plain water at least 30 minutes before food or other drugs. Remaining upright for at least 30 minutes reduces the risk of esophagitis. Taking it with food or calcium markedly lowers absorption, and lying down increases esophageal injury.

Why the other options are wrong

  • A) Food and juice greatly reduce absorption.
  • B) Lying down increases the risk of esophageal injury.
  • C) Calcium binds alendronate, and bedtime dosing risks esophagitis.

Key point: Bisphosphonates: plain water, empty stomach, upright 30 minutes.

Question 2 · Parenteral insulin

A hospital's diabetic ketoacidosis protocol calls for a continuous IV insulin infusion. Which insulin should the pharmacy use to prepare it?

  1. AInsulin NPH
  2. BInsulin glargine
  3. CInsulin degludec
  4. DInsulin regular
Show the answer

Answer: D) Insulin regular

Insulin regular is a clear solution and is the standard insulin for IV infusion (e.g., 100 units in 100 mL NS for DKA). NPH is a suspension, which must never be given IV. Glargine depends on precipitating at the subcutaneous site and degludec on forming multihexamers under the skin; neither is intended for IV infusion.

Why the other options are wrong

  • A) NPH is a suspension and must never be given IV.
  • B) Glargine relies on precipitating under the skin; it is not intended for IV use.
  • C) Degludec relies on forming multihexamers under the skin; it is not used IV.

Key point: Only clear, short-acting insulin (regular) goes in an IV insulin infusion. Never give suspensions IV.

Question 3 · Prescription calculation

A patient uses insulin glargine 100 units/mL, 32 units daily. Each pen holds 3 mL. Allowing 2 units for priming each day, how many days will a box of 5 pens last?

  1. A39 days
  2. B44 days
  3. C47 days
  4. D50 days
Show the answer

Answer: B) 44 days

Each box: 5 pens x 3 mL x 100 units/mL = 1,500 units. Daily use: 32 + 2 = 34 units. 1,500 / 34 = 44.1, so about 44 days.

Why the other options are wrong

  • A) 39 days uses too large a daily amount (about 38 units a day).
  • C) 47 days ignores the priming dose altogether (1,500 ÷ 32 = 46.9).
  • D) 50 days subtracts the 2 priming units instead of adding them (1,500 ÷ 30).

Key point: Insulin days supply: total units ÷ (daily dose + priming). Don't forget the priming.

Question 4 · Diabetes prevention

K.B., 50, has prediabetes (A1C 6.2%) and a BMI of 31 kg/m2. Which of the following interventions has the strongest evidence for preventing progression to type 2 diabetes?

  1. ALifestyle program targeting 7% weight loss and 150 min/week of activity
  2. BHigh-dose daily vitamin D supplementation
  3. CMetformin alone, without any diet or physical activity changes
  4. DAnnual A1C and fasting glucose monitoring alone, with no other intervention
Show the answer

Answer: A) Lifestyle program targeting 7% weight loss and 150 min/week of activity

Intensive lifestyle intervention (about 5-10% weight loss through diet and at least 150 minutes per week of moderate activity) reduced progression to type 2 diabetes by about 58% in the Diabetes Prevention Program, more than metformin (about 31%), and is the first-line approach recommended by Diabetes Canada. Vitamin D has not been shown to prevent diabetes, and monitoring alone does not alter risk.

Why the other options are wrong

  • B) Vitamin D supplements have not been shown to prevent type 2 diabetes.
  • C) Metformin reduced progression less (about 31%) than lifestyle change in the DPP.
  • D) Monitoring alone finds diabetes later but does not lower the risk.

Key point: Prediabetes: intensive lifestyle change beats metformin for preventing type 2 diabetes.

Question 5 · Diabetes

N.T., a 54-year-old woman with type 2 diabetes, is prescribed semaglutide (Ozempic) subcutaneous injection. Which of the following is the most appropriate starting regimen?

  1. A1 mg once weekly starting with the very first dose
  2. B0.25 mg once daily for 1 week, then 0.5 mg once daily
  3. C0.5 mg once weekly for 4 weeks, then 2 mg once weekly
  4. D0.25 mg once weekly for 4 weeks, then 0.5 mg weekly
Show the answer

Answer: D) 0.25 mg once weekly for 4 weeks, then 0.5 mg weekly

Semaglutide injection is started at 0.25 mg once weekly for 4 weeks to improve gastrointestinal tolerability (the 0.25 mg dose is not a maintenance dose), then increased to 0.5 mg weekly; further increases to 1 mg and then 2 mg occur at intervals of at least 4 weeks if needed. Starting at 1 mg increases nausea and vomiting, semaglutide injection is not dosed daily, and jumping from 0.5 to 2 mg skips the 1 mg step.

Why the other options are wrong

  • A) Starting at 1 mg skips titration and causes more nausea and vomiting.
  • B) Semaglutide injection is dosed once weekly, not daily.
  • C) Starting at 0.5 mg skips the 0.25 mg step, and jumping to 2 mg skips 1 mg.

Key point: Ozempic: 0.25 mg weekly x 4 weeks, then 0.5 mg; increase every 4+ weeks.

Question 6 · Storage

A patient has just started using a new insulin glargine 100 units/mL pen. Which of the following is the most appropriate storage advice for the pen that is currently in use?

  1. AKeep it in the refrigerator between injections and use it until the expiry date printed on the pen label
  2. BKeep it in the freezer compartment to prolong stability
  3. CKeep it at room temperature (up to 30 °C) away from heat and light; discard 28 days after first use
  4. DKeep it at room temperature, away from light, and use it until the manufacturer's expiry date
Show the answer

Answer: C) Keep it at room temperature (up to 30 °C) away from heat and light; discard 28 days after first use

Unopened insulin glargine pens are stored in the refrigerator (2-8 °C), but the in-use pen should be kept at room temperature (up to 30 °C), protected from heat and light, and discarded 28 days after first use even if insulin remains. Refrigerating the in-use pen is not recommended by the manufacturer, freezing destroys insulin, and the printed expiry date does not apply once the pen is in use.

Why the other options are wrong

  • A) The manufacturer does not recommend refrigerating the in-use pen, and the printed expiry stops applying once in use.
  • B) Freezing destroys insulin.
  • D) Room temperature is right, but the in-use pen must be discarded 28 days after first use, not at the printed expiry.

Key point: In-use glargine pen: room temperature up to 30 C, discard 28 days after first use.

Question 7 · Diabetes

S.P., a 24-year-old woman with type 1 diabetes on basal-bolus insulin, plans to drink alcohol at a party tonight. Which of the following is the most appropriate counselling?

  1. ASkip her basal insulin dose tonight to prevent hypoglycemia
  2. BEat carbohydrate while drinking and check glucose overnight
  3. CAvoid eating while drinking because alcohol raises blood glucose
  4. DTake extra rapid-acting insulin with each alcoholic drink
Show the answer

Answer: B) Eat carbohydrate while drinking and check glucose overnight

Alcohol inhibits hepatic gluconeogenesis and can cause delayed hypoglycemia, sometimes up to 24 hours later, and its symptoms may be mistaken for intoxication. People using insulin should consume carbohydrate with alcohol, monitor glucose more frequently including before bed and overnight, and wear medical identification. Skipping basal insulin in type 1 diabetes risks DKA, and taking extra insulin with drinks increases hypoglycemia risk.

Why the other options are wrong

  • A) Skipping basal insulin in type 1 diabetes risks diabetic ketoacidosis.
  • C) Alcohol lowers glucose by blocking gluconeogenesis, so eating is needed, not avoided.
  • D) Extra rapid-acting insulin with drinks increases the risk of severe hypoglycemia.

Key point: Alcohol with insulin: eat carbs, check glucose overnight; delayed lows up to 24 h.

Question 8 · Prescription calculation

An insulin infusion of regular insulin 100 units in 100 mL NS is ordered at 0.1 units/kg/hour for an 80-kg adult in DKA. Which of the following is the correct infusion rate?

  1. A0.8 mL/hour
  2. B8 mL/hour
  3. C10 mL/hour
  4. D80 mL/hour
Show the answer

Answer: B) 8 mL/hour

Dose = 0.1 units/kg/hour × 80 kg = 8 units/hour. The concentration is 100 units ÷ 100 mL = 1 unit/mL, so the rate is 8 mL/hour. 0.8 mL/hour and 80 mL/hour are tenfold errors, and 10 mL/hour does not match the weight-based dose.

Why the other options are wrong

  • A) 0.8 mL/hour is a tenfold underdose.
  • C) 10 mL/hour doesn't match 0.1 units/kg/hour for 80 kg.
  • D) 80 mL/hour is a tenfold overdose.

Key point: Weight-based infusion: dose per hour ÷ concentration. Standard insulin infusions are often 1 unit/mL.

Question 9 · Hyperthyroidism in pregnancy

XL, a 30-year-old woman who is 8 weeks pregnant, is diagnosed with Graves' hyperthyroidism requiring antithyroid drug therapy. Which of the following is the most appropriate choice?

  1. APropylthiouracil
  2. BLevothyroxine
  3. CMethimazole
  4. DRadioactive iodine
Show the answer

Answer: A) Propylthiouracil

Propylthiouracil is preferred during the first trimester because methimazole is associated with congenital malformations (e.g., aplasia cutis, choanal/esophageal atresia) when used during organogenesis; switching to methimazole is often considered after the first trimester because of PTU hepatotoxicity. Radioactive iodine is contraindicated in pregnancy. Levothyroxine treats hypothyroidism, not hyperthyroidism.

Why the other options are wrong

  • B) Levothyroxine treats hypothyroidism, not Graves'.
  • C) Methimazole is associated with congenital malformations in the first trimester.
  • D) Radioactive iodine is contraindicated in pregnancy.

Key point: Hyperthyroidism in pregnancy: PTU in the first trimester, methimazole after.

Question 10 · Corticosteroids

HV, a 60-year-old woman, has taken prednisone 30 mg daily for 4 months for polymyalgia rheumatica and wants to stop it now because of weight gain. Which of the following is correct?

  1. APrednisone must be tapered gradually because of adrenal suppression
  2. BPrednisone can be stopped if she takes it every other day for 1 week
  3. CPrednisone can be stopped if hydrocortisone cream is used instead
  4. DPrednisone can be stopped because adrenal suppression occurs only above 40 mg
Show the answer

Answer: A) Prednisone must be tapered gradually because of adrenal suppression

Adrenal suppression can occur with oral glucocorticoid doses above about 4 to 6 mg of prednisone daily taken for 3 to 4 weeks or longer, so 30 mg daily for 4 months certainly suppresses the hypothalamic-pituitary-adrenal axis. Abrupt discontinuation can cause acute adrenal insufficiency and disease flare, so the dose must be tapered gradually under prescriber guidance, more slowly near physiologic doses. Topical hydrocortisone does not replace systemic glucocorticoid, and suppression occurs far below 40 mg daily.

Why the other options are wrong

  • B) Every-other-day dosing for a week isn't an adequate taper after 4 months.
  • C) Topical hydrocortisone doesn't replace systemic steroids.
  • D) Suppression can occur above about 4-6 mg/day of prednisone for 3-4 weeks, far below 40 mg.

Key point: Prednisone above about 5 mg/day for 3-4 weeks or longer: taper, don't stop abruptly.

Find your weakest topics

The free diagnostic grades you across all six PEBC competencies, then builds a study plan around the areas costing you the most marks. We also have 2,000+ practice questions and 98 OSCE stations where you talk to an AI patient out loud.

Take the free diagnosticTry a free OSCE station

More free study guides